Your browser doesn't support javascript.
loading
Corrigendum to "Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial" [Gynecologic Oncology 161 (2021) 143-151].
Janda, Monika; Robledo, Kristy P; Gebski, Val; Armes, Jane E; Alizart, Michelle; Brennan, Donal; Cummings, Margaret; Chen, Chen; Leung, Yee; Sykes, Peter; McNally, Orla; Oehler, Martin K; Garrett, Andrea; Tang, Amy; Land, Russell; Nicklin, James L; Chetty, Naven; Perrin, Lewis C; Hoet, Greet; Sowden, Katherine; Eva, Lois; Tristram, Amanda; Obermair, Andreas.
Afiliación
  • Janda M; Centre for Health Services Research, The University of Queensland, QLD, Australia.
  • Robledo KP; University of Sydney NHMRC Clinical Trials Centre, Sydney, NSW, Australia.
  • Gebski V; University of Sydney NHMRC Clinical Trials Centre, Sydney, NSW, Australia.
  • Armes JE; Sunshine Coast University Hospital Laboratory, Birtinya, QLD, Australia.
  • Alizart M; Sullivan Nicolaides Pathology, QLD, Australia.
  • Brennan D; UCD Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Eccles Street, Dublin, Ireland.
  • Cummings M; University of Queensland Centre for Clinical Research, Brisbane, QLD, Australia; Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, Australia.
  • Chen C; School of Biomedical Sciences, University of Queensland, Brisbane, Australia.
  • Leung Y; Division of Obstetrics and Gynaecology, The University of Western Australia,WA, Australia.
  • Sykes P; Christchurch Women's Hospital, Canterbury District Health Board, Christchurch, New Zealand; University of Otago, Christchurch, New Zealand.
  • McNally O; Department of Oncology and Dysplasia, Royal Women's Hospital, Melbourne, VIC, Australia; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, VIC, Australia.
  • Oehler MK; Royal Adelaide Hospital, Adelaide, SA, Australia.
  • GraemeWalker; Gold Coast University Hospital, QLD, Australia.
  • Garrett A; Queensland Centre for Gynaecological Cancer Research, The University of Queensland, QLD, Australia; Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
  • Tang A; Queensland Centre for Gynaecological Cancer Research, The University of Queensland, QLD, Australia; Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
  • Land R; Queensland Centre for Gynaecological Cancer Research, The University of Queensland, QLD, Australia; Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
  • Nicklin JL; Queensland Centre for Gynaecological Cancer Research, The University of Queensland, QLD, Australia; Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
  • Chetty N; Queensland Centre for Gynaecological Cancer Research, The University of Queensland, QLD, Australia; Mater Health Services, Brisbane, Australia.
  • Perrin LC; Queensland Centre for Gynaecological Cancer Research, The University of Queensland, QLD, Australia; Mater Health Services, Brisbane, Australia.
  • Hoet G; The Townsville Hospital, Townsville, QLD, Australia.
  • Sowden K; Middlemore Hospital, Auckland, New Zealand.
  • Eva L; National Women's Health, Auckland City Hospital, Auckland, New Zealand.
  • Tristram A; Wellington Regional Hospital, Wellington, New Zealand.
  • Obermair A; Queensland Centre for Gynaecological Cancer Research, The University of Queensland, QLD, Australia; Royal Brisbane and Women's Hospital, Herston, QLD, Australia. Electronic address: ao@surgicalperformance.com.
Gynecol Oncol ; 162(2): 526, 2021 Aug.
Article en En | MEDLINE | ID: mdl-34053746

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Gynecol Oncol Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Gynecol Oncol Año: 2021 Tipo del documento: Article País de afiliación: Australia